137 related articles for article (PubMed ID: 26460937)
1. MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma.
Tesser-Gamba F; Lopes LJ; Petrilli AS; Toledo SR
Mol Carcinog; 2016 Nov; 55(11):1700-1713. PubMed ID: 26460937
[TBL] [Abstract][Full Text] [Related]
2. MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7.
Dong X; Lv B; Li Y; Cheng Q; Su C; Yin G
Arch Biochem Biophys; 2017 Sep; 630():47-53. PubMed ID: 28734729
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase 7 promotes cell proliferation, migration and invasion in SOSP-M human osteosarcoma cell line.
Huang Y; Yao J; Zhu B; Zhang J; Sun T
Tumori; 2017 Sep; 103(5):483-488. PubMed ID: 26350187
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7.
Hou Y; Feng H; Jiao J; Qian L; Sun B; Chen P; Li Q; Liang Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2065-2071. PubMed ID: 31126193
[No Abstract] [Full Text] [Related]
5. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-187 suppresses the proliferation migration and invasion of human osteosarcoma cells by targeting MAPK7.
Liu M; Wu L; Cai C; Liu L; Xu Y
J BUON; 2020; 25(1):472-478. PubMed ID: 32277671
[TBL] [Abstract][Full Text] [Related]
7. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
8. Role of MAPK7 in cell proliferation and metastasis in ovarian cancer.
Dai J; Wang T; Wang W; Zhang S; Liao Y; Chen J
Int J Clin Exp Pathol; 2015; 8(9):10444-51. PubMed ID: 26617753
[TBL] [Abstract][Full Text] [Related]
9. MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma.
Tesser-Gamba F; Paolillo AT; Del Giúdice Paniago M; Petrilli AS; Seixas Alves MT; Garcia Filho RJ; Toledo SRC
Ann Diagn Pathol; 2020 Jun; 46():151482. PubMed ID: 32145682
[TBL] [Abstract][Full Text] [Related]
10. DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
Shi JH; Hao YJ
Biochem Biophys Res Commun; 2019 Mar; 510(4):525-529. PubMed ID: 30738579
[TBL] [Abstract][Full Text] [Related]
11. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
13. MAPK7 and MAP2K4 as prognostic markers in osteosarcoma.
Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Filho RJ; Juliano Y; Toledo SR
Hum Pathol; 2012 Jul; 43(7):994-1002. PubMed ID: 22154052
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
Gavine PR; Wang M; Yu D; Hu E; Huang C; Xia J; Su X; Fan J; Zhang T; Ye Q; Zheng L; Zhu G; Qian Z; Luo Q; Hou YY; Ji Q
BMC Cancer; 2015 Jun; 15():454. PubMed ID: 26040563
[TBL] [Abstract][Full Text] [Related]
15. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
16. ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9.
Kim SM; Lee H; Park YS; Lee Y; Seo SW
J Orthop Res; 2012 Jul; 30(7):1040-4. PubMed ID: 22213073
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
18. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
19. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of PIM kinases in osteosarcoma.
Mou S; Wang G; Ding D; Yu D; Pei Y; Teng S; Fu Q
Int J Oncol; 2016 Nov; 49(5):2116-2126. PubMed ID: 27826617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]